Exposure to volatile organic compounds and loss of pulmonary function in the elderly

Yoon H.I., Hong Y-C., Cho S-H., Kim H., Kim Y.H., Sohn J.R., Kwon M., Park S-H., Cho M-H., Cheong H-K.

Source: Eur Respir J 2010; 36: 1270-1276
Journal Issue: December
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yoon H.I., Hong Y-C., Cho S-H., Kim H., Kim Y.H., Sohn J.R., Kwon M., Park S-H., Cho M-H., Cheong H-K.. Exposure to volatile organic compounds and loss of pulmonary function in the elderly. Eur Respir J 2010; 36: 1270-1276

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Combined effect of volatile organic compounds on respiratory health in adults
Source: Annual Congress 2010 - Indoor air and respiratory disease
Year: 2010

Exhaled volatile organic compounds in nonrespiratory diseases
Source: Eur Respir Monogr 2010; 49: 140-151
Year: 2010


Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015



Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Diet and alcohol affect exhaled volatile organic compounds (VOCs)
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Effect of oxygen on breath markers of oxidative stress
Source: Eur Respir J 2003; 21: 48-51
Year: 2003



Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003

Microbial volatile organic compounds (MVOC) and plasticizers in schools in relation to asthma and respiratory symptoms among pupils
Source: Eur Respir J 2006; 28: Suppl. 50, 698s
Year: 2006

Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Volatile organic chemicals contribute to airway hyperresponsiveness
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003

Overview of the antioxidant pathways in relation to effects of air pollution
Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=241
Year: 2002